Neonatal intensive care unit at Shands children's hospital at the Univeristy of Florida
Gainesville, Florida, 32504, United States
Location status: Recruiting
Location contact
Leslie A Parker, PhD
CONTACT
Leslie A Parker, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06000761
Premature infants are susceptible to complications related to infrequent and non-standardized oral care. Although the benefits of frequent standardized oral care are known to reduce oral dysbiosis (increased level of potentially pathogenic bacteria) and its associated complications in critically ill adults leading to established evidence-based guidelines, no such information exists for VLBW infants. The proposed study will prospectively follow 168 VLBW infants for 4 weeks following birth.
Interested in participating?
Request Info1 hour–3 day
All sexes
Interventional
Not applicable
Gainesville, Florida, 32504, United States
Location status: Recruiting
Leslie A Parker, PhD
CONTACT
Leslie A Parker, PhD
PRINCIPAL_INVESTIGATOR
Premature very low birth weight (VLBW) infants are susceptible to complications related to infrequent and non-standardized oral care. Although the benefits of frequent standardized oral care are known to reduce oral dysbiosis (increased level of potentially pathogenic bacteria) and its associated complications in critically ill adults leading to established evidence-based guidelines, no such information exists for VLBW infants. Premature VLBW infants are highly susceptible to costly, life threatening and potentially preventable morbidities, such as ventilator associated pneumonia (VAP), bronchopulmonary dysplasia (BPD; oxygen requirement at 28 days of life) and need for prolonged respiratory support which require additional treatments, increase cost of care, and can lead to chronic illness, re-hospitalization, and developmental delay. A dearth of information exists regarding oral care in VLBW infants, and no such guidelines exist for infants admitted to the neonatal intensive care unit (NICU) which may negatively affect their health. Thus, research regarding the effect of frequent, standardized oral care on the health of VLBW infants is essential to develop guidelines thus potentially improving the health of this vulnerable population. If successful, this research could change practice in NICUs across the nation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion:
Exclusion:
One sponge-tipped swab, saturated with sterile water or human milk, will used clean the oral cavity with 15 seconds each area. Surfaces include all 4 quadrants of the gum surface and upper posterior part of the oropharynx. A second swab, with sterile water or milk will be used on the ventral and posterior surfaces of the tongue. A third swab, saturated with sterile water or human milk, will be used to clean the outer surface of any dwelling oral tubes (endotracheal tube, NAVA or feeding tube). Lips will be cleaned with a sterile gauze saturated with sterile water or human milk. Oral cavity will be suctioned as needed with an oral suction devise to remove secretions.
Time frame: 0-28 days
Oral samples will be obtained weekly and the microbiome analyzed using rRNA 16s sequencing
Time frame: 0-28 days
Evidence of ventilator pneumonia will be assessed weekly over the first 4 weeks of life
Time frame: 0-60 days
Evidence of bronchopulmonary dysplasia will be assessed weekly over the first 60 days of life
Time frame: 0-60 days
Days the infant was on any type of respiratory support will be assessed daily for the first 60 days of life
Contact information is provided by the study sponsor or research team.
University of Florida
Other
Frequent Standardized Oral Care Using Human Milk to Prevent Oral Dysbiosis and Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05767671
Acute Respiratory Distress Syndrome, Cross Infection
Denver, Colorado, United States
View Trial DetailsNCT05354778
Cross Infection, Disease Attributes
São Paulo, Sao Paulo SP, Brazil
View Trial DetailsNCT05591924
ARDS, Cognition Disorders
London, Ontario, Canada
View Trial DetailsNCT06092554
Brain Diseases, Brain Injuries
Brussels, Belgium
View Trial Details